Additionally, a large study in 168 patients with glioma with different WHO grade identified that decreased NDRG1 expression was negatively correlated with WHO grade; moreover, low expression of NDRG1 was associated with significantly lower OS, independent of any prognostic factors [30]. This evidence concerns the gene NDRG1 and central nervous system cancer.